242 related articles for article (PubMed ID: 12780754)
1. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth.
Greenman Y; Ouaknine G; Veshchev I; Reider-Groswasser II; Segev Y; Stern N
Clin Endocrinol (Oxf); 2003 Jun; 58(6):763-9. PubMed ID: 12780754
[TBL] [Abstract][Full Text] [Related]
2. The natural history of surgically treated but radiotherapy-naïve nonfunctioning pituitary adenomas.
O'Sullivan EP; Woods C; Glynn N; Behan LA; Crowley R; O'Kelly P; Smith D; Thompson CJ; Agha A
Clin Endocrinol (Oxf); 2009 Nov; 71(5):709-14. PubMed ID: 19302582
[TBL] [Abstract][Full Text] [Related]
3. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
[TBL] [Abstract][Full Text] [Related]
5. Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth.
Greenman Y; Tordjman K; Osher E; Veshchev I; Shenkerman G; Reider-Groswasser II; Segev Y; Ouaknine G; Stern N
Clin Endocrinol (Oxf); 2005 Jul; 63(1):39-44. PubMed ID: 15963059
[TBL] [Abstract][Full Text] [Related]
6. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma.
Dekkers OM; Pereira AM; Roelfsema F; Voormolen JH; Neelis KJ; Schroijen MA; Smit JW; Romijn JA
J Clin Endocrinol Metab; 2006 May; 91(5):1796-801. PubMed ID: 16507632
[TBL] [Abstract][Full Text] [Related]
7. The transsphenoidal removal of nonfunctioning pituitary adenomas with suprasellar extensions: the open sella method and intentionally staged operation.
Saito K; Kuwayama A; Yamamoto N; Sugita K
Neurosurgery; 1995 Apr; 36(4):668-75; discussion 675-6. PubMed ID: 7596495
[TBL] [Abstract][Full Text] [Related]
8. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
Bradley KJ; Wass JA; Turner HE
Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
[TBL] [Abstract][Full Text] [Related]
9. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study.
Turner HE; Stratton IM; Byrne JV; Adams CB; Wass JA
Clin Endocrinol (Oxf); 1999 Sep; 51(3):281-4. PubMed ID: 10469006
[TBL] [Abstract][Full Text] [Related]
10. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.
Colao A; Ferone D; Lombardi G; Lastoria S
Clin Endocrinol (Oxf); 2002 Jun; 56(6):713-21. PubMed ID: 12072040
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenomas: results of 684 surgically treated patients and review of the literature.
Oruçkaptan HH; Senmevsim O; Ozcan OE; Ozgen T
Surg Neurol; 2000 Mar; 53(3):211-9. PubMed ID: 10773251
[TBL] [Abstract][Full Text] [Related]
12. MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomas.
Soto-Ares G; Cortet-Rudelli C; Assaker R; Boulinguez A; Dubest C; Dewailly D; Pruvo JP
Eur J Endocrinol; 2002 Feb; 146(2):179-86. PubMed ID: 11834426
[TBL] [Abstract][Full Text] [Related]
13. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas.
Chang EF; Zada G; Kim S; Lamborn KR; Quinones-Hinojosa A; Tyrrell JB; Wilson CB; Kunwar S
J Neurosurg; 2008 Apr; 108(4):736-45. PubMed ID: 18377253
[TBL] [Abstract][Full Text] [Related]
14. Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study.
Honegger J; Ernemann U; Psaras T; Will B
Acta Neurochir (Wien); 2007 Jan; 149(1):21-9; discussion 29. PubMed ID: 17086476
[TBL] [Abstract][Full Text] [Related]
15. Impact of ultra-low-field intraoperative magnetic resonance imaging on extent of resection and frequency of tumor recurrence in 104 surgically treated nonfunctioning pituitary adenomas.
Hlavica M; Bellut D; Lemm D; Schmid C; Bernays RL
World Neurosurg; 2013 Jan; 79(1):99-109. PubMed ID: 23043996
[TBL] [Abstract][Full Text] [Related]
16. Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma.
Sheehan JP; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2002 Dec; 97(5 Suppl):408-14. PubMed ID: 12507066
[TBL] [Abstract][Full Text] [Related]
17. The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas.
Park P; Chandler WF; Barkan AL; Orrego JJ; Cowan JA; Griffith KA; Tsien C
Neurosurgery; 2004 Jul; 55(1):100-6; discussion 106-7. PubMed ID: 15214978
[TBL] [Abstract][Full Text] [Related]
18. The postoperative monitoring of nonfunctioning pituitary adenomas.
Wass JA; Reddy R; Karavitaki N
Nat Rev Endocrinol; 2011 Apr; 7(7):431-4. PubMed ID: 21467969
[TBL] [Abstract][Full Text] [Related]
19. Transsphenoidal pituitary macroadenomas resection guided by PoleStar N20 low-field intraoperative magnetic resonance imaging: comparison with early postoperative high-field magnetic resonance imaging.
Wu JS; Shou XF; Yao CJ; Wang YF; Zhuang DX; Mao Y; Li SQ; Zhou LF
Neurosurgery; 2009 Jul; 65(1):63-70; discussion 70-1. PubMed ID: 19574826
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp Grades 0-2 nonfunctioning pituitary macroadenomas at a single institution.
Dallapiazza R; Bond AE; Grober Y; Louis RG; Payne SC; Oldfield EH; Jane JA
J Neurosurg; 2014 Sep; 121(3):511-7. PubMed ID: 24995783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
